CORT

David L. Mahoney

Known title: DirectorCIK: 0001224091

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 4, 2026

CORT Featured in Low-Beta Healthcare Stock List. Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.

this person other insiders at CORT

Transaction History

CORT▼ Sell$48K
CORT▼ Sell$585K
CORT▼ Sell$10.8M
CORT▼ Sell$839K
CORT▼ Sell$1.7M
CORT▲ Buy$176K
CORT▼ Sell$176K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▲ Buy$197K
CORT▼ Sell$197K
CORT▼ Sell$1.8M
CORT▼ Sell$263K
CORT▲ Buy$52K
CORT▼ Sell$0
CORT▼ Sell$52K
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$0
CORT▼ Sell$309K
CORT▼ Sell$464K
CORT▲ Buy$52K
CORT▼ Sell$52K
CORT▲ Buy$122K
CORT▼ Sell$122K

We use analytics to understand how market-wall is used. No personal data is sold.